One vaccine. One dose. One visit.
One dose of Prevnar 20Ⓡ provides lasting protection against 20 strains of the bacteria that cause both pneumococcal pneumonia and invasive pneumococcal disease, like meningitis or blood infection.*
*Based on a clinical study for Prevnar 13Ⓡ showing protection for approximately 4 years. Prevnar 20 and Prevnar 13 are manufactured and formulated similarly and contain 13 of the same polysaccharide conjugates.
Expanded CDC recommendation for adults 50+
If you’re 50 or older, the CDC now recommends that you get vaccinated to help protect yourself against pneumococcal pneumonia and invasive pneumococcal disease.
Talk to your doctor to see if Prevnar 20 is right for you.
Pneumococcal pneumonia and invasive pneumococcal disease can strike in any season.
Pneumococcal disease can be serious and could put you in the hospital. Prevnar 20 can help protect eligible adults against 20 different strains of the bacteria that cause pneumococcal pneumonia and invasive pneumococcal disease.
You may be at increased risk if you are:
19 or older with certain chronic conditions
Conditions include diabetes, asthma, COPD, chronic heart disease, or chronic kidney failure.
Adults taking certain medicines
that suppress the immune system
are also at increased risk.
Prevnar vaccines have been used by millions and millions of adults in the US for over 10 years† with a demonstrated safety profile.
†Prevnar includes Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) and Prevnar 20. In the US, Prevnar 13 was available for adults from 2012 to 2024.